Jane Street
ABCL icon

Jane Street’s AbCellera Biologics ABCL Stock Holding History

Jane Street’s Portfolio ABCL Stock Details ABCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.96M Sell
847,883
-549,205
-39% -$1.98M ﹤0.01% 4372
2025
Q4 		$4.78M Buy
1,397,088
+999,944
+252% +$4.46M ﹤0.01% 3299
2025
Q3 		$2M Buy
397,144
+303,164
+323% +$1.34M ﹤0.01% 4936
2025
Q2 		$322K Buy
+93,980
New +$234K ﹤0.01% 7727
2025
Q1 		– Sell
-128,407
Closed -$368K – 9286
2024
Q4 		$376K Buy
128,407
+22,455
+21% +$62.5K ﹤0.01% 7340
2024
Q3 		$275K Sell
105,952
-48,820
-32% -$135K ﹤0.01% 8168
2024
Q2 		$458K Buy
154,772
+55,887
+57% +$211K ﹤0.01% 7168
2024
Q1 		$448K Sell
98,885
-144,555
-59% -$738K ﹤0.01% 6863
2023
Q4 		$1.39M Buy
243,440
+131,348
+117% +$609K ﹤0.01% 4958
2023
Q3 		$516K Sell
112,092
-25,154
-18% -$153K ﹤0.01% 6257
2023
Q2 		$887K Buy
137,246
+88,124
+179% +$601K ﹤0.01% 5402
2023
Q1 		$370K Buy
49,122
+29,251
+147% +$266K ﹤0.01% 6836
2022
Q4 		$201K Sell
19,871
-5,230
-21% -$60.4K ﹤0.01% 7660
2022
Q3 		$248K Sell
25,101
-16,401
-40% -$180K ﹤0.01% 7854
2022
Q2 		$442K Buy
+41,502
New +$351K ﹤0.01% 6953
2022
Q1 		– Sell
-384,146
Closed -$3.64M – 10173
2021
Q4 		$5.49M Buy
384,146
+303,389
+376% +$4.6M ﹤0.01% 2708
2021
Q3 		$1.62M Sell
80,757
-33,964
-30% -$600K ﹤0.01% 4920
2021
Q2 		$2.52M Buy
114,721
+74,954
+188% +$2.07M ﹤0.01% 3883
2021
Q1 		$1.35M Buy
39,767
+24,844
+166% +$990K ﹤0.01% 4834
2020
Q4 		$601K Buy
+14,923
New +$682K ﹤0.01% 5456

Other funds holding ABCL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $33.7B AUM 35.49% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Jane Street's ABCL Position: Q1 2026 in Review

Jane Street reduced its AbCellera Biologics (ABCL) stake by 39% in Q1 2026, selling an estimated $1.98M and leaving 847,883 shares worth $2.96M. The position accounts for ﹤0.01% of the portfolio, ranked #4372.

Jane Street first reported a position in ABCL in Q4 2020 and has held it in 20 quarters since. The position peaked at $5.49M in Q4 2021. 138 funds tracked by Wall St. Rank hold ABCL as of Q1 2026.

  • Jane Street held 847,883 shares of AbCellera Biologics worth $2.96M as of Q1 2026.
  • Jane Street sold 549,205 AbCellera Biologics shares in Q1 2026, an estimated $1.98M.
  • AbCellera Biologics made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #4372 holding.
  • Jane Street first reported a position in AbCellera Biologics in Q4 2020 and has held it in 20 quarters since.
  • Jane Street's AbCellera Biologics position peaked at $5.49M in Q4 2021.
  • 138 funds tracked by Wall St. Rank held AbCellera Biologics as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.